A Prototype Worldwide Survey of Diagnostic and Treatment Modalities for Stroke

Journal of Stroke and Cerebrovascular Diseases

Volumn 24, Issue 2, 2015, Pages 290-296

  Aiyagari, Venkatesh ^a   Pandey, Dilip K ^b   Testai, Fernando D ^b   Grysiewicz, Rebbeca A ^b   Tsiskaridze, Alexander ^c   Sacks, Claudio ^d   Ogun, Yomi ^e   Ogunrin, Olubunmi A ^f   Uthman, Basim M ^g   Lindsay, Patrice ^h   Gorelick, Philip B ⁱ  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c Department of Neurology Sarajishvili Institute of Neurology and Neurosurgery   (Georgia)

^d UNIVERSIDAD DE VALPARAÍSO   (Chile)

^e Aruna Ogun MSHosp   (Nigeria)

^f UNIVERSITY OF BENIN   (Nigeria)

^g WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^h HEART AND STROKE FOUNDATION OF CANADA   (Canada)

ⁱ MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

acute treatment of stroke; clinical protocols; health care surveys; Stroke; stroke prevention

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BLOOD CLOT LYSIS; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DAY HOSPITAL; DOPPLER FLOWMETRY; FIBRINOLYTIC THERAPY; HEALTH CARE SURVEY; HEALTH EDUCATION; HEALTH SURVEY; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; INCOME; NEUROLOGIST; PRIORITY JOURNAL; PROPHYLAXIS; STROKE PATIENT; TRANSTHORACIC ECHOCARDIOGRAPHY; VENOUS THROMBOEMBOLISM; BRAIN ISCHEMIA; PROCEDURES; STROKE;

BRAIN ISCHEMIA; ENDARTERECTOMY, CAROTID; FIBRINOLYTIC AGENTS; HEALTH CARE SURVEYS; HUMANS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84922837628     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2014.08.002     Document Type: Article

References (22)

1. A.D. Lopez, C.D. Mathers, and M. Ezzati Global and regional burden of disease and risk factors, 2001: systemic analysis of population health data Lancet 367 2006 1747 1757
2. V.L. Felgin, C.M.M. Lawes, and D. Bennett Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case fatality in the late 20th century Lancet Neurol 2 2003 43 53
3. V.L. Feigin Stroke in developing countries: can the epidemic be stopped and outcomes improved? Lancet Neurol 6 2007 94 97
4. S.C. Johnston, S. Mendis, and C.D. Mathers Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and mortality Lancet Neurol 8 2009 345 354
5. K. Asplund What MONICA told us about stroke Lancet Neurol 4 2005 64 68
6. S. Strong, C. Mathers, and R. Bonita Preventing stroke: saving lives around the world Lancet Neurol 6 2007 182 187
7. M. Brainin, Y. Teuschl, and L. Kalra Acute treatment and long-term management of stroke in developing countries Lancet Neurol 6 2007 553 561
8. F. de los Ríos la Rosa, and J.P. Broderick Toward a modern delivery of stroke care in emerging economies J Stroke Cerebrovasc Dis 22 2013 e1 3
9. Available at: http://www.worldstrokecampaign.org/2012/Pages/Home.aspx accessed Nov 17, 2013.
10. V.L. Feigin, and R. Krishnamurthi Public health strategies could reduce the global stroke epidemic Lancet Neurol 9 2010 847 848
11. R. Bonita, and R. Beaglehole Stroke prevention in poor countries: time for action Stroke 38 2007 2871 2872
12. T. Truelsen, P.U. Heuschmann, and R. Bonita A standard tool for developing stroke registers in low and middle income countries: experiences from a feasibility study of a stepwise approach to stroke surveillance (STEPS Stroke) Lancet Neurol 6 2007 134 139
13. K.S. Reddy, B. Shah, and C. Varghese Responding to the threat of chronic diseases in India Lancet 366 2005 1744 1749
14. P.M. Lavados, A.J.M. Hennis, and M.T. Medina Stroke epidemiology, prevention, and management strategies at a regional level: Latin America and the Caribbean Lancet Neurol 6 2007 362 372
15. M. Liu, B. Wu, and W.Z. Wang Stroke in China: epidemiology, prevention, and management strategies Lancet Neurol 6 2007 456 464
16. D. Lemogoum, J.P. Degaute, and P. Bovet Stroke prevention, treatment, and rehabilitation in sub-Saharan Africa Am J Prev Med 29 2005 95 101
17. E. Kadusevicius, D. Jankauskiene, and I. Paulauskaite Policy implications of statin use in Lithuania Int J Technol Assess Health Care 25 2009 419 424
18. S. Yusuf, S. Islam, and C.K. Chow Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE study): a prospective epidemiological survey Lancet 378 2011 1231 1243
19. P. Langhorne, L. de Villiers, and J.D. Pandian Applicability of stroke-unit care to low-income and middle-income countries Lancet Neurol 11 2012 341 348
20. F.J. Carod-Artal Policy implications of the changing epidemiology of Chagas disease and stroke Stroke 44 2013 2356 2360
21. J.D. Pandian, V. Padma, and P. Vijaya Stroke and thrombolysis in developing countries Int Journal of Stroke 2 2007 17 26
22. D.V. Araújo, V. Teich, and R.B. Passos Analysis of the cost-effectiveness of thrombolysis with alteplase in stroke Arq Bras Cardiol 95 2010 12 20